iShares Evolved U.S. Healthcare Staples
ALTAR
Score™
5.6% info Recommen-
dation
NEUTRAL
2019E    2020E
P/E
ratio
21.8x P/Sales
ratio
1.3x
P/BV
ratio
3.5x Div.
yield
1.1%


  • Description
  • Performance
  • Comps
  • premium Fundamentals
  • premium Valuation
  • premium Rating
IEHS tracks an index that offers US healthcare exposure as defined by the iShares Evolved Sector classification scheme.

FUND BASICS
Category US Equities
Fund Sponsor BlackRock
Website www.ishares.com
Inception date Mar 21, 2018
Assets (mns) $12
Currency USD
Expense ratio 18 bp
Distributions Quarterly

FUND STRUCTURE
Regulation Open-Ended Fund
Custodian
Weighting Fundamental
Index replication
Uses derivatives No
Options available No

SECTOR BREAKDOWN

 


CONSTITUENT BREAKDOWN
No. of constituents 162
Wgt avg mkt cap (mns) $106,152
Large cap (>$10bn) 89.7%
Mid cap ($2-10bn) 8.2%
Small cap (<$2bn) 2.1%
Developed mkts 100.0%
Emerging mkts 0.0%

TOP TEN HOLDINGS
UNITEDHEALTH GROUP INC 11.4 %
MEDTRONIC PLC 7.5 %
ABBOTT LABORATORIES 6.4 %
THERMO FISHER SCIENTIFIC INC 3.9 %
JOHNSON & JOHNSON 3.7 %
CVS CAREMARK CORP 3.3 %
DANAHER CORP 3.3 %
STRYKER CORP 3.3 %
INTUITIVE SURGICAL INC 3.3 %
BECTON DICKINSON AND CO 3.3 %
Total 49.4 %

TOP COUNTRY EXPOSURE
UNITED STATES 90.2 %
IRELAND 8.7 %
BRITAIN 0.3 %
NETHERLANDS 0.1 %
CANADA 0.0 %






HISTORICAL PERFORMANCE info

  Custom date range Compare to  
  thru


Standardized Annual Returns (thru December 31)
Year-to-date 1 year 5 years 10 years Since Incep.
24.1% 24.1% -- -- 16.6%

Market Correlations
versus... Beta R-squared
S&P500 0.85 68%
MSCI EAFE 0.80 44%
MSCI Emg. Mkts. 0.55 34%

Technical Indicators
Recent close $32.89
30d moving avg. $31.92
Annualized volatility 15.5%
Short interest (ETF) 0.0%
Relative strength (RSI) 70

Liquidity measures
Avg. volume (thou.) 3
Turnover 0.9%
Bid/Ask (% of price) 0.10%
ADV underlying (mns) $21,124

Distributions


FINDING ALTERNATIVE FUNDS

Below is a list of 20 potential alternatives to the iShares Evolved U.S. Healthcare Staples ETF based on the alternatives' overlap in portfolio holdings with IEHS. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.

Benchmark ticker: IEHS Expense: 18 bp ALTAR Score™: 5.6%


ALTERNATIVE ETFs BASED ON OVERLAP WITH IEHS
Ticker Fund
Name
Overlap1
vs IEHS
(%)
Expense
ratio
(bp)
Savings
vs IEHS
(bp)
ALTAR
Score™
(%)
ALTAR
vs IEHS
(%)
XLV Health Care Select Sector SPDR 58.9 13 5 6.8 +1.3
IYH iShares US Healthcare 58.0 43 -25 5.9 +0.4
FHLC Fidelity MSCI Health Care 57.6 8 10 5.5 -0.1
VHT Vanguard Health Care 57.5 10 8 5.5 -0.0
JHMH John Hancock Multifactor Health Care 55.4 40 -22 6.3 +0.7
IHI iShares DJ US Medical Devices 47.1 43 -25 3.6 -1.9
RYH Invesco S&P Equal Weight Healthcare 46.8 40 -22 6.7 +1.1
IXJ iShares S&P Global Healthcare 42.6 46 -28 6.0 +0.4
FXH First Trust Health Care Alphadex 34.7 63 -45 6.7 +1.1
GDNA Goldman Sachs Motif Human Evolution 32.0 50 -32 1.0 -4.6
IHF iShares US Healthcare Providers 30.9 43 -25 7.1 +1.5
XHE SPDR S&P Health Care Equipment 25.5 35 -17 2.0 -3.6
LNGR Global X Longevity Thematic 24.3 50 -32 3.2 -2.3
XHS SPDR S&P Health Care Services 22.1 35 -17 5.2 -0.4
HTEC Robo Global Healthcare Technology and Innovation 20.0 68 -50 -0.6 -6.1
HLAL Wahed FTSE USA Shariah 18.7 50 -32 5.3 -0.3
PTH Invesco DWA Healthcare Momentum 18.4 60 -42 -3.5 -9.0
CLRG IQ Chaikin U.S. Large Cap 16.7 25 -7 7.7 +2.2
ESGL Invesco ESG Revenue ETF 16.0 40 -22 7.5 +2.0
MGV Vanguard Mega Cap 300 Value 15.6 7 11 6.8 +1.2

1Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.

Content on this tab for subscribers only**

RESULTS & ESTIMATES

  2014 2015 2016 2017 2018 2019E 2020E
Sales per share ** ** ** ** ** ** **
Earnings per share ** ** ** ** ** ** **
Dividends per share info ** ** ** ** ** ** **
Book value per share ** ** ** ** ** ** **

 

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

OTHER FUNDAMENTAL METRICS

Long term EPS growth est. **%   Debt-to-equity **x
Asset turnover **%   Assets-to-equity **x

Return on equity

Revision activity*
*Six months ago = 100

Net margins

Compound annual growth rates

Content on this tab for subscribers only

VALUATION METRICS
  2018 2019E 2020E
Price-to-sales ** ** **
Price-to-earnings ** ** **
Price-to-cash flow ** ** **
Price-to-growth ** ** **
Price-to-book value ** ** **
Yield ** ** **

Historical valuation trends

Forward
multiple:
iShares Evolved U.S. Healthcare Staples
Relative
to:
S&P500 MSCI EAFE MSCI Emg. Mkts. Other ETF:

NEUTRAL

Average appreciation potential. A rating of NEUTRAL is assigned to ETFs with ALTAR Scores in the middle quintile (ranking between 40%-60%) of their category. This indicates that valuations adequately reflect the fundamentals of stocks in these funds.

ALTAR Score™


Calculation of ALTAR Score™
Avg. Return on Equity 17.6 %
Divided by: Fwd. P/BV 3.1 x
Less: Expense ratio 18 bp
Equals: ALTAR Score 5.6 %
info More information on ALTAR Score™

MODERN PORTFOLIO THEORY info

CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS
COMPOSITE
RATING
1.36 CATEGORY
AVERAGE
1.55
 
The composite rating is a weighted average of analysts' consensus recommendations for individual ETF constituents, based on the following scale:

BUY = 1; OVERWEIGHT = 1.5, HOLD = 2; UNDERWEIGHT = 2.5; and SELL = 3.

Readers are cautioned that because analyst ratings tend to be inflated, the composite score may be more useful as a relative measure of sentiment between funds rather than as a stand-alone recommendation.
 

 

See RATING tab for calculation of ALTAR Score™
Risk & reward. Uses std. dev. as proxy for risk, ALTAR Score™ for return forecast.
Dividends paid by constituents to the fund. May differ from actual distributions to shareholders due to constituent changes, timing issues or other factors.
Monthly returns based on changes in price plus dividends. May differ from daily returns reported by funds. See below for standardized returns.